Drug Pipeline

APG777 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-09 NCT07003425
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis		 Trial sites expanded: 50 -> 56 locations
2026-05-16 NCT07003425
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis		 Trial sites expanded: 45 -> 48 locations
Active Studies by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07003425 A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis Atopic Dermatitis Recruiting
NCT06395948 A Study Evaluating APG777 in Atopic Dermatitis Atopic Dermatitis Active, Not Recruiting
Phase 1
NCT06920901 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity… Asthma Active, Not Recruiting
NCT07027527 An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in… Atopic Dermatitis Active, Not Recruiting
Sponsors Running APG777 Trials
Apogee Therapeutics, Inc. (4)
Disease Areas
Atopic Dermatitis (3) Asthma (1)
Get alerts when APG777 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free